Action Alert - August Recess
Moving Forward for the Kids
Every parent knows the anxiety of a child’s lingering headache or change in behavior. But for some families, that concern turns into a nightmare with the words, “Your child has a brain tumor.” In an instant, childhood is replaced by hospital visits, risky surgeries, and treatments no child or family should endure. Pediatric brain cancer is the deadliest form of childhood cancer, impacting lives in unimaginable ways. These children and their families urgently need our support. Together, we can drive research, improve care, and offer hope.
At the Pediatric Brain Tumor Foundation (PBTF), our mission is clear: Care. Cure. Thrive. We exist to fund research, support families, and fight for a future where a brain tumor diagnosis isn’t a life sentence. Today, the landscape of pediatric cancer research is shifting beneath our feet. We face significant setbacks with the closing of vital research networks, yet we also see new horizons of hope opening through groundbreaking federal funding.
This moment requires us to be louder, stronger, and more united than ever. Because when it comes to saving our children, there are no sides—only the urgent need to do better.
The Loss of a Critical Ally: The PBTC Closing
For over 25 years, the Pediatric Brain Tumor Consortium (PBTC) has been a cornerstone in the fight against childhood brain tumors. As an NCI-funded, multi-institutional clinical trials consortium, PBTC has led many of the most promising early-phase and investigator-initiated clinical trials for children with brain tumors in North America. It represented hope for families who had been told there were “no other options.”
Recent decisions to end National Cancer Institute (NCI) funding for the PBTC have sent shockwaves through the pediatric oncology community. The wind-down of this consortium is not just an administrative change; it threatens to stall critical research momentum built over decades.
What This Means for Families
The closure brings immediate, tangible fears for families currently navigating this journey.
We believe that every child deserves the option to participate in research that could save their life. The dismantling of such a vital network forces us to ask tough questions about how we prioritize our children’s health at a federal level.
PBTF’s Role: Unwavering Advocacy
In the face of these challenges, the Pediatric Brain Tumor Foundation stands as a leader in advocacy. We are not just watching these changes happen; we are actively working to ensure the mission moves forward.
Advocacy is more than policy; it’s about protecting the vulnerable. Our families deserve better than funding freezes and closed doors. They deserve a system that fights as hard for their children as they do.
We are calling on our community to stay engaged. We are working with clinicians, researchers, and policymakers to safeguard the data and progress made by the PBTC. We must ensure that the transition of these trials is transparent and that the stewardship of decades of research data remains secure.
A New Beacon of Hope: ARPA-H and the PCX Program
While the news of the PBTC closing is heavy, we must also look toward the light. Just as one chapter faces challenges, another is being written with the potential to revolutionize how we treat complex pediatric diseases.
The Advanced Research Projects Agency for Health (ARPA-H) has announced a groundbreaking $50 million investment to launch the Pediatric Care eXpansion (PCX) program. This isn’t just funding; it’s a structural shift in how we approach pediatric care.
Why PCX Matters
The PCX program is designed to do exactly what parents have been praying for: speed up the timeline.
This initiative represents the best of what is possible when we invest in our children. It brings together the brightest minds in technology, including commitments from industry giants like Amazon, Microsoft, and Google, to apply the power of AI and cloud computing to pediatric health.
A Non-Partisan Mission: Kids Can’t Wait
Cancer does not care about political affiliations. It takes away childhoods, and addressing it is a shared responsibility that goes beyond politics.
The struggle to fund pediatric cancer research—which historically receives only 4-8% of federal cancer research funding – remains an uphill battle. Whether it is protecting existing networks like the PBTC, celebrating new investments like the Executive Order harnessing American AI innovation to unlock cures for pediatric cancer, or supporting transformative efforts like the newly launched ARPA-H, our focus must remain singular: the kids.
When we advocate for funding, we aren’t asking for a handout. We are investing in our future. We are saying that a child’s life is worth more than a budget cut. This is not just an investment in research—it’s an investment in humanity, in hope, and in the future we owe our children.
Moving the Mission Forward
At the Pediatric Brain Tumor Foundation, we are committed to navigating this complex landscape. We will continue to fund early-stage research, support families through the darkest days, and advocate relentlessly for policies that prioritize children.
But we cannot do it alone.
Join Us
Your voice matters. Whether you are a parent, a survivor, or simply someone who believes that children deserve a chance to grow up, we need you.
Together, we can ensure that every child with a brain tumor has the chance to Care, Cure, and Thrive.